Development Strategy
Short-Term Goal (2024-2026)
Short-Term Goal (2024-2026)
Short-Term Goal (2024-2026)
- Promote Vairnew to enter the clinical trial stage and complete clinical studies as soon as possible
- Promote the application and approval of Bhmintbh products 510k
Mid-term Goal (2026-2030)
Short-Term Goal (2024-2026)
Short-Term Goal (2024-2026)
- Completed FDA registration, successfully launched, and expanded market penetration,
- Merger and acquisition